.

Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
QuintilesIMS
McKinsey
Citi
Dow
Accenture
Cerilliant
Queensland Health
Healthtrust
Johnson and Johnson

Generated: November 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 203163

« Back to Dashboard
NDA 203163 describes ASHLYNA, which is a drug marketed by Glenmark Generics and is included in one NDA. It is available from one supplier. Additional details are available on the ASHLYNA profile page.

The generic ingredient in ASHLYNA is ethinyl estradiol; levonorgestrel. There are twenty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; levonorgestrel profile page.

Summary for 203163

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 203163

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ASHLYNA
ethinyl estradiol; levonorgestrel
TABLET;ORAL 203163 ANDA Glenmark Generics Inc., USA 68462-646 68462-646-93 2 POUCH in 1 CARTON (68462-646-93) > 1 BLISTER PACK in 1 POUCH > 1 KIT in 1 BLISTER PACK (68462-646-91)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength0.03MG,0.01MG;0.15MG,N/A
Approval Date:Feb 23, 2015TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Medtronic
Julphar
Baxter
Daiichi Sankyo
US Army
Colorcon
Citi
Cipla
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot